Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Galmed Pharmaceuticals Ltd. (GLMD)

https://www.galmedpharma.com

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/13/2014

Market Cap

1,716,957

Shares Outstanding

3,810,000

Weighted SO

4,006,832

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

EVFMD --.--%

AFMD --.--%

ABEO --.--%

AKBA --.--%

KOD --.--%

MREO --.--%

ADVM --.--%

ADAP --.--%

PIRS --.--%

Beta

0.6900

Last Div

0.0000

Range

0.26-0.9

Chg

-0.0142

Avg Vol

49408

Mkt Cap

1716957

Exch

NASDAQ

Country

IL

Phone

972 3 693 8448

DCF Diff

-0.7006

DCF

1.0605

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.0200

P/FV

0.1223

Div Yield %

0.0000

P/E

-0.2454

PEG

-0.0032

Payout

0.0000

Current Ratio

6.3354

Quick Ratio

6.5456

Cash Ratio

0.8952

DSO

0.0000

DIO

-3302.8049

Op Cycle

0.0000

DPO

12312.0732

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0216

ROA

-0.4378

ROE

-0.4822

ROCE

-0.5402

NI/EBT

1.0000

EBT/EBIT

0.9225

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-1378.2000

CF/Debt

0.0000

Equity Multi

1.1384

Rec Turnover

0.0000

Pay Turnover

0.0296

Inv Turnover

-0.1105

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.1486

FCF/Share

-1.1486

Cash/Share

2.0012

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.1223

P/B

0.1223

P/S

0.0000

P/E

-0.2454

P/FCF

-0.2737

P/OCF

-0.2487

P/CF

-0.2487

PEG

-0.0032

P/S

0.0000

EV Multiple

-0.0200

P/FV

0.1223

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation